source
- Novo Holdings backs European fund; Alnylam sends second obesity drug into clinicPlus news about IMU Biosciences, Autobahn and Jade Biosciences. 💸 Novo Holdings invests in Europe-focused fund: The investment manager of the Novo Nordisk Foundation's fortunes is backing the Scal…Endpoints · 1mo ago↗ source
- STAT+: AI titans push Congress for DNA safeguardsInceptive Nucleics and Alnylam's partnership, why Grail's "failed" trial still matters, and other biotech news from The ReadoutSTAT · 1mo ago↗ source
- STAT+: Utah Medical Board scolded for going rogue with AI criticismIn this edition of STAT Health Tech: An update on the Utah pilot that uses a chatbot to renew drug prescriptions, AI scribes for patients, and more.STAT · 1mo ago